|
Boston Scientific's Device To Relieve Severe Asthma: A Major Opportunity
Seeking Alpha Earlier in 2012 Boston Scientific's incoming CEO Michael Mahoney said about the Alair asthma treatment that it will be marketed in 20 countries and 200 sites by the end of the 2012. Mahoney predicted that the worldwide market for bronchial thermoplasty … |
View full post on asthma – Google News